Tianyu Biotech announced that in 2024, revenue was 802 million yuan, an increase of 19.55% over the previous year. Net loss attributable to shareholders of listed companies was 107 million yuan, compared with a net loss of 462 million yuan for the same period last year.

Zhitongcaijing · 5d ago
Tianyu Biotech announced that in 2024, revenue was 802 million yuan, an increase of 19.55% over the previous year. Net loss attributable to shareholders of listed companies was 107 million yuan, compared with a net loss of 462 million yuan for the same period last year.